Acorda Therapeutics, Inc. (ACOR) - NASDAQ
From other sites
Company Description
Acorda Therapeutics, Inc. engages in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system. The company's two main products are Ampyra and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States